The stock market is at record high.. During this time this pharma stock has given huge returns to the investors. Has given 650 percent return in just six months.
New Delhi. With the NSE Nifty, BSE Sensex, mid-cap and small-cap indices hitting record highs, some stocks in 2021 turned multibagger stocks 2021. entered in the list. Shares of ANG Lifesciences are one of them. This pharma stock has increased from ₹ 85.50 per stock level to ₹ 642.10 (Today 12:44 PM on BSE) in last six months. It has given about 650 percent return to its shareholders in this period.
ANG Lifesciences Share Price History In the last 5 trading sessions, this stock has closed its highest at ₹744.70 per share, but could not sustain higher levels and today fell from these levels to ₹642.10 per equity share. However, in the last one month, this pharma stock has risen from ₹527 per share to ₹642.10 per stock level. There has been an increase of about 22 percent during this period. Similarly, in the last six months, this multibagger stock has increased from ₹85.50 per stock level to ₹642.10. This company has given returns close to 650 percent to its shareholders.
Investors became rich in 6 months According to the price history of this multibagger stock, if an investor had invested ₹ 1 lakh in this counter a month ago, then ₹ 1 lakh would have become ₹ 1.22 lakh in this period. Similarly, if an investor had invested ₹1 lakh in this counter 3 months back, his ₹1 lakh would have become ₹3.56 lakh as the multibagger stock increased from ₹180.35 per equity share (closing price on 16 June 2021) ₹ 642.10 is done. During this time, about 3.56 times more increase has been seen in this stock.
However, if an investor had invested ₹ 1 lakh in this counter six months ago and continued with it, today his ₹ 1 lakh would have become ₹ 7.50 lakh.
How will the strategy go ahead?
Investors are being suggested to buy this multibagger stock for more profit. According to Sumeet Bagdia, Executive Director, Choice Broking, “One can buy this counter at the current market price by maintaining a stop loss target of ₹750 to ₹800.”
